knowledge -WSS

knowledge

author：focus 2025-09-30 18:16:25 - browse：583

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： Biohaven protein

Wikipedia

WSS

7 more heat

What will save rural psychiatry services? Higher Medicaid payments

AI used to predict Covid

Latest bird flu infection made farmworker sicker than earlier cases

Vir antibody drug aimed at influenza A fails in clinical trial

Dark money group runs ads on China biotech bill

focus

knowledge

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Indian pharmaceutical industry in denial over drug

Novavax promises a turnaround & Lilly roils the obesity market

AI used to predict Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

AI used to predict Covid

Continuity nursing helped my family in our darkest PICU moments

Average age of first period drops to 11.9 years, study shows

The high cost of giving birth even with insurance

EF3 tornado rips through North Carolina amid extreme weather nationwide

explore

AI used to predict Covid

Lab trade group sues FDA to halt regulation of lab

Childbirth

Study identifies new proteins linked to dementia risk 25 years later

7 more heat

Judge rejects Trump's request to move Stormy Daniels hush

Wikipedia

Wikipedia

entertainment

focus